Results 11 to 20 of about 877 (137)

Management of Failed Bioprosthetic Aortic Valves: Mitigating Complications and Optimizing Outcomes

open access: yesJournal of Interventional Cardiology, 2022
The use of bioprosthetic prostheses during surgical aortic valve replacements has increased dramatically over the last two decades, accounting for over 85% of surgical implantations.
Elizabeth L. Norton   +3 more
doaj   +1 more source

Bioprosthetic Valve Thrombosis

open access: yesCardiology Research, 2018
Degenerative valve disease is on the rise with greater than 100,000 valve operations performed in the US alone per year. The majority of those procedures employ tissue bioprostheses to avoid the attendant risk of anticoagulation, especially in the elderly. Though traditionally this approach has been considered a superior option to avoid anticoagulation,
Sachdev, Sarina   +3 more
openaire   +3 more sources

Bioprosthetic Aortic Valve on the Move

open access: yesCASE, 2022
[Figure: see text]
Ioannis Milioglou   +2 more
openaire   +2 more sources

Unexpected bioprosthetic mitral valve thrombus during left ventricular assist device implantation

open access: yesJA Clinical Reports, 2017
Acute bioprosthetic valve thrombosis can occur after surgery and sometimes cause hemodynamic instability and cardiogenic shock. Risk factors for bioprosthetic valve thrombosis are hypercoagulability, atrial fibrillation, atrial dilatation, low cardiac ...
Tatsuyuki Imada   +3 more
doaj   +1 more source

Bioprosthetic Valve Thrombosis

open access: yesJournal of the American College of Cardiology, 2017
Bioprosthetic valve (BPV) thrombosis is considered a relatively rare clinical entity. Yet a more recent analysis involving a more systematic echocardiographic follow-up, the advent of transcatheter heart valve (THV) technologies coupled with the highly sensitive nature of 4-dimensional computed tomographic imaging for detecting subclinical thrombi upon
Puri, Rishi   +2 more
openaire   +4 more sources

Bioprosthetic heart valves of the future [PDF]

open access: yesXenotransplantation, 2014
AbstractGlutaraldehyde‐fixed bioprosthetic heart valves (GBHVs), derived from pigs or cows, undergo structural valve deterioration (SVD) over time, with calcification and eventual failure. It is generally accepted that SVD is due to chemical processes between glutaraldehyde and free calcium ions in the blood.
Rizwan A, Manji   +3 more
openaire   +2 more sources

Modern understanding of mechanisms of bioprosthetic valve structural degeneration: a literature review

open access: yesРоссийский кардиологический журнал, 2018
Bioprosthetic valves are often used to replace diseased heart valves. They differ from mechanical valves by optimal hemodynamic parameters and low thrombogenicity.
A. E. Kostyunin   +2 more
doaj   +1 more source

Transcatheter heart valve in valve implantation with Edwards SAPIEN bioprosthetic valve for different degenerated bioprosthetic valve positions (First Iranian ViV report with mid-term follow up) [PDF]

open access: yesJournal of Cardiovascular and Thoracic Research, 2017
Introduction: After early successful experience with transcatheter aortic valve replacement (TAVR), concept of transcatheter implantation of a new valve within a failing bioprosthetic valve emerged. Valve-in-valve (ViV) implantation seems to be a simpler
Ali Mohammad Haji Zeinali   +4 more
doaj   +1 more source

Degenerated TAVR Within Degenerated Surgical Bioprosthetic Valve Treated With Second TAVR

open access: yesJACC: Case Reports, 2020
Transcatheter aortic valve replacement within a degenerated surgical bioprosthetic aortic valve is increasing in frequency. We present a rare case of a patient requiring a second TAVR placed within a previous placed degenerated transcatheter aortic valve,
Muhammad Ajmal, MD   +4 more
doaj   +1 more source

Midterm outcomes of mechanical versus bioprosthetic valve replacement in middle-aged patients: An Indian scenario

open access: yesHeart India, 2017
Objective: The goal of this study is to evaluate and compare the midterm outcomes of bioprosthetic heart valve replacement in terms of survival, valve-related events, quality of life, and economic aspects of treatment in population age 45 years and above
Dheeraj Sharma   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy